A phase I pharmacokinetic study of HMN-214, a novel oral stilbene derivative with polo-like kinase-1-interacting properties, in patients with advanced solid tumors

Linda L. Garland, Charles Taylor, Deborah L. Pilkington, Jan L. Cohen, Daniel D. Von Hoff

Research output: Contribution to journalArticlepeer-review

70 Scopus citations

Fingerprint

Dive into the research topics of 'A phase I pharmacokinetic study of HMN-214, a novel oral stilbene derivative with polo-like kinase-1-interacting properties, in patients with advanced solid tumors'. Together they form a unique fingerprint.

Medicine & Life Sciences